Instruments

Name Stock exchange Average volume Price Type
NASH DOM BULGARIA HOLDING AD HDOM

Bulgaria S.E. +1 Other

8 0.061 BGN Stock Nash Dom Bulgaria Holding AD Stock
NASH DOM BULGARIA HOLDING AD 0OI9

London S.E.

- - BGN Stock Nash Dom Bulgaria Holding AD
MICHAEL HILL INTERNATIONAL LIMITED MHJ

Australian S.E. +1 Other

100,639 0.625 AUD Stock Michael Hill International Limited Stock
MICHAEL HILL INTERNATIONAL LIMITED MHJ

New Zealand S.E.

37,690 0.7 NZD Stock Michael Hill International Limited
MICHAEL ANTHONY HOLDINGS, INC. MAJJ

OTC Markets

0 1,800 USD Stock Michael Anthony Holdings, Inc. Stock
MICHAEL / STROM OBLIGACJI KORPORACYJNYCH FIZ MSOKFIZ

Warsaw S.E.

25 1,399 PLN Stock Michael / Strom Obligacji Korporacyjnych FIZ Stock
RSE ARCHIVE LLC - MEMBERSHIP INTERESTS SERIES - 1984 MICHAEL JORDAN DEBUT FUND RMJDS

OTC Markets

38 1.3 USD Stock Rse Archive Llc - Membership Interests Series - 1984 Michael Jordan Debut Fund Stock
RSE ARCHIVE, LLC - MEMBERSHIP INTERESTS SERIES - 85 JORDAN1985 MICHAEL JORDAN ROOKIE SNEAKERS FUND RSSMS

OTC Markets

0 16 USD Stock RSE Archive, LLC - Membership Interests Series - 85 Jordan1985 Michael Jordan Rookie Sneakers Fund Stock
RSE ARCHIVE LLC - MEMBERSHIP INTERESTS SERIES - 1998 UPPER DECK MICHAEL JORDAN JERSEY FUND RVVJS

OTC Markets

37 8 USD Stock Rse Archive LLC - Membership Interests Series - 1998 Upper Deck Michael Jordan Jersey Fund Stock
RSE ARCHIVE, LLC - MEMBERSHIP INTERESTS SERIES - 85MJPROMO 1985 MICHAEL JORDAN PROMO ROOKIE CARD FD RSSIS

OTC Markets

- - USD Stock RSE Archive, LLC - Membership Interests Series - 85MJPROMO 1985 Michael Jordan Promo Rookie Card Fd Stock
RSE ARCHIVE, LLC - MEMBERSHIP INTERESTS SERIES - 03JORDAN 2003-04 UD MICHAEL JORDAN CARD FUND RSEFS

OTC Markets

- - USD Stock RSE Archive, LLC - Membership Interests Series - 03jordan 2003-04 Ud Michael Jordan Card Fund Stock

News (1675)

Transcript : Ligand Pharmaceuticals Incorporated, Q1 2024 Earnings Call, May 07, 2024
Artists from Universal Music Group are heading back to TikTok as new licensing deal reached AQ
Transcript : Universal Music Group N.V., Q1 2024 Earnings Call, May 02, 2024
Transcript : Novo Nordisk A/S, Q1 2024 Earnings Call, May 02, 2024
TikTok to Welcome Back Universal Music Artists After New Licensing Agreement -- 2nd Update DJ
Inventiva : Présentation corporate avril 2024 PU
Transcript : Gilead Sciences, Inc., Q1 2024 Earnings Call, Apr 25, 2024
Transcript : Ally Financial Inc., Q1 2024 Earnings Call, Apr 18, 2024
Transcript : CarMax, Inc., Q4 2024 Earnings Call, Apr 11, 2024
Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024
Transcript : Inventiva S.A. - Special Call
Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D GL
Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D AQ
Transcript : Madrigal Pharmaceuticals, Inc. - Special Call
Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell AQ
Inventiva : Corporate Presentation March 2024 PU
Citi Trends Announces Refresh of Board of Directors BU
UMG targets 250 mln euros in savings by 2026, flags job cuts RE
Transcript : Universal Music Group N.V., Q4 2023 Earnings Call, Feb 28, 2024
Transcript : KBR, Inc., Q4 2023 Earnings Call, Feb 20, 2024
Transcript : Capital One Financial Corporation, Discover Financial Services - M&A Call
ENDRA Life Sciences Bolsters TAEUS System Intellectual Property with New Patents in U.S., China and Europe AQ
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe BU
Transcript : CoinShares International Limited, Q4 2023 Earnings Call, Feb 13, 2024
Transcript : Amgen Inc., Q4 2023 Earnings Call, Feb 06, 2024
Transcript : Novo Nordisk A/S, 2023 Earnings Call, Jan 31, 2024
Transcript : Discover Financial Services, Q4 2023 Earnings Call, Jan 18, 2024
Hudson Pacific Properties, Inc. Announces Board Changes CI
Madrigal Pharmaceuticals Presents Five Health Economics Outcomes Research Abstracts at the NASH-TAG Annual Conference CI
Madrigal Pharmaceuticals Presents Five Health Economics Outcomes Research Abstracts at the NASH-TAG Annual Conference AQ
NeuroBo to Participate in Industry and Investor Conferences in January PR
Transcript : CarMax, Inc., Q3 2024 Earnings Call, Dec 21, 2023
NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split PR
Transcript : Westpac Banking Corporation - Shareholder/Analyst Call
Transcript : Alnylam Pharmaceuticals, Inc. - Special Call
Barclays Recognizes 81 New Managing Directors in the Corporate and Investment Bank BU
Hudson Pacific Appoints Michael Nash to Board of Directors BU
Hudson Pacific Properties, Inc. Announces Board Changes CI
Transcript : Vivoryon Therapeutics N.V., Q3 2023 Earnings Call, Dec 06, 2023
CAN-FITE'S NAMODENOSON FOR THE TREATMENT OF PANCREATIC CANCER PATIENTS, PROGRESS IN CLINICAL DEVELOPMENT AQ
Transcript : Zealand Pharma A/S - Special Call
Inventiva announces the positive recommendation of the third DMC of the Phase III clinical trial with lanifibranor in patients with NASH GL
Inventiva announces the positive recommendation of the third DMC of the Phase III clinical trial with lanifibranor in patients with NASH AQ
NEUROBO TO PARTICIPATE IN INVESTOR CONFERENCES IN DECEMBER AQ
Can-Fite’s Namodenoson for the Treatment of Pancreatic Cancer Patients: Progress in Clinical Development BU
1234NextSee all

Companies (65)

ESTEE LAUDER 46 642 M $
Logo Estee Lauder

The Estée Lauder Companies Inc. is one of the 1st world cosmetics groups. Products are sold under brands (Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le La ...

ESTEE LAUDER 46 642 M $
Logo Estee Lauder

The Estée Lauder Companies Inc. is one of the 1st world cosmetics groups. Products are sold under brands (Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le La ...

CAPRI HOLDINGS LIMITED 4 165 M $
Logo Capri Holdings Limited

Capri Holdings Limited is a holding company, which owns brands that are designers, marketers, distributors and retailers of women’s and men’s accessories, footwear and ready-to-wear bearing the Versace, Jimmy Choo and Michael Kors tradenames and relat ...

MADRIGAL PHARMACEUTICALS, INC. 5 014 M $
Logo Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directe ...

INGERSOLL RAND INC. 35 696 M $
Logo Ingersoll Rand Inc.

Ingersoll Rand Inc. specializes in the design, manufacture and marketing of industrial technological equipment. The group provides compressed air equipment (screw compressors, reciprocating compressors, centrifugal compressors, air dryers, air filters, et ...

ZYDUS LIFESCIENCES LIMITED 12 303 M $
Logo Zydus Lifesciences Limited

Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product ...

CYTODYN INC. 150 M $
Logo CytoDyn Inc.

CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (C ...

AKERO THERAPEUTICS, INC. 1 529 M $
Logo Akero Therapeutics, Inc.

Akero Therapeutics, Inc. is a clinical-stage company. The Company is developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis (MASH), ...

NASH DOM BULGARIA HOLDING AD 182 723 $
Logo Nash Dom Bulgaria Holding AD

Nash Dom Bulgaria Holding AD Sofia (Nash Dom-Bulgaria AD-Holding or Nash Dom Bulgaria Holding PLC) is a Bulgaria-based holding company that is principally engaged in the acquisition, appraisal and managing of shares in companies active in the food process ...

ASCLETIS PHARMA INC. 181 M $
Logo Ascletis Pharma Inc.

Ascletis Pharma Inc is a China-based investment holding company principally engaged in the research, development, production, marketing and sales of pharmaceutical products. The Company mainly focuses on viral diseases, non-alcoholic steatohepatitis (NASH ...


1234Next

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW